Drug factory · FDA FEI 1000330416
Curia Italy S.r.l.
Viale Europa 5, Origgio, Italy
No problems found at FDA's last inspection, Nov 17, 2022.
No Action Indicated: inspectors found no objectionable conditions.
5 drug inspections on record since 2010: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Minocycline | Makes the active ingredient and tests it | Melinta Therapeutics, LLC | 70842-160 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 17, 2022 | No problems found | Drug Quality Assurance | — |
| May 17, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 18, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 28, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 13, 2010 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.